Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study.
Fabi A, Metro G, Vidiri A, Lanzetta G, Carosi M, Telera S, Maschio M, Russillo M, Sperduti I, Carapella CM, Cognetti F, Pace A. Fabi A, et al. Among authors: carapella cm. J Neurooncol. 2010 Nov;100(2):209-15. doi: 10.1007/s11060-010-0163-3. Epub 2010 Mar 30. J Neurooncol. 2010. PMID: 20352471 Clinical Trial.
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme.
Metro G, Fabi A, Mirri MA, Vidiri A, Pace A, Carosi M, Russillo M, Maschio M, Giannarelli D, Pellegrini D, Pompili A, Cognetti F, Carapella CM. Metro G, et al. Among authors: carapella cm. Cancer Chemother Pharmacol. 2010 Jan;65(2):391-7. doi: 10.1007/s00280-009-1155-x. Epub 2009 Oct 22. Cancer Chemother Pharmacol. 2010. PMID: 19847425 Clinical Trial.
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F, Vidiri A, Schillaci O, Floris R, Marzi S, Fabi A, Pace A. Villani V, et al. Among authors: carapella cm. Anticancer Res. 2015 Sep;35(9):5117-22. Anticancer Res. 2015. PMID: 26254416
Comorbidities in elderly patients with glioblastoma: a field-practice study.
Villani V, Tanzilli A, Telera SM, Terrenato I, Vidiri A, Fabi A, Zucchella C, Carapella CM, Marucci L, Casini B, Carosi M, Oppido PM, Pace A. Villani V, et al. Among authors: carapella cm. Future Oncol. 2019 Mar;15(8):841-850. doi: 10.2217/fon-2018-0524. Epub 2019 Jan 18. Future Oncol. 2019. PMID: 30656982
End of life issues in brain tumor patients.
Pace A, Di Lorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A. Pace A, et al. Among authors: carapella cm. J Neurooncol. 2009 Jan;91(1):39-43. doi: 10.1007/s11060-008-9670-x. Epub 2008 Aug 14. J Neurooncol. 2009. PMID: 18704267
Levetiracetam therapy in patients with brain tumour and epilepsy.
Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B. Maschio M, et al. Among authors: carapella cm. J Neurooncol. 2006 Oct;80(1):97-100. doi: 10.1007/s11060-006-9162-9. Epub 2006 May 10. J Neurooncol. 2006. PMID: 16685465 Clinical Trial.
87 results